Home The Word Brain	My Amedeo FAQ Privacy About	Flying Publisher
	The Angels Initiative Stroke prevention

Malignant Lymphoma

Free Subscription Articles published in Eur J Immunol Retrieve available abstracts of 7 articles: HTML format

Single Articles

February 2023
1. GUPTA DD, Lohoff M
   Puppet masters of b cell progenitor acute lymphoblastic leukemia: the preb cell receptor and the interleukin 7 receptor alpha.
   Eur J Immunol. 2023 Feb 20:e2250093. doi: 10.1002/eji.202250093.
   PubMed     Abstract available
   
   
   December 2022
2. MORRISH E, Wartewig T, Kratzert A, Rosenbaum M, et al
   The fusion oncogene VAV1-MYO1F triggers aberrant T-cell receptor signalling in vivo and drives peripheral T-cell lymphoma in mice.
   Eur J Immunol. 2022 Dec 21:e2250147. doi: 10.1002/eji.202250147.
   PubMed     Abstract available
   
   
   August 2022
3. L'IMPERIO V, Morello G, Vegliante MC, Cancila V, et al
   Spatial transcriptome of a germinal center plasmablastic burst hints at MYD88/CD79B mutants-enriched diffuse large B-cell lymphomas.
   Eur J Immunol. 2022;52:1350-1361.
   PubMed     Abstract available
   
   
   May 2022
4. SUMMERAUER AM, Jaggi V, Ogwang R, Traxel S, et al
   Epstein-Barr virus and malaria upregulate AID and APOBEC3 enzymes, but only AID seems to play a major mutagenic role in Burkitt lymphoma.
   Eur J Immunol. 2022 May 3. doi: 10.1002/eji.202249820.
   PubMed     Abstract available
   
   
   October 2021
5. KREMER AE, Kremer AN, Willam C, Volkl S, et al
   Successful treatment of COVID-19 infection with convalescent plasma in B-cell-depleted patients may promote cellular immunity.
   Eur J Immunol. 2021;51:2478-2484.
   PubMed     Abstract available
   
   
   September 2021
6. RIP J, de Bruijn MJW, Neys SFH, Singh SP, et al
   Bruton's tyrosine kinase inhibition induces rewiring of proximal and distal B-cell receptor signaling in mice.
   Eur J Immunol. 2021;51:2251-2265.
   PubMed     Abstract available
   
   
   April 2021
7. NICOLAY JP, Albrecht JD, Alberti-Violetti S, Berti E, et al
   CCR4 in cutaneous T-cell lymphoma: therapeutic targeting of a pathogenic driver.
   Eur J Immunol. 2021 Apr 3. doi: 10.1002/eji.202049043.
   PubMed     Abstract available
   
   

Thank you for your interest in scientific medicine.

AMEDEO Malignant Lymphoma is free of charge. This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim. Design: